HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.

Willy Le Roi Togna PaboJoseph FokamDebimeh NjumeDésiré TakouMaria-Mercedes SantoroRaymond Babila NyasaCollins ChenwiMarie Laure MpouelGrace BeloumouEzechiel Semengue Ngoufack JagniAlex Durand NkaAude Christelle Ka'eGeorges TetoBeatrice DambayaSandrine DjupsaDavy Hyacinthe Gouissi AnguechiaMolimbou EvaristeCedric KamtaLionel BalaVirginie LamboEdie Gregory Halle-EkaneVittorio ColizziCarlo Federico PernoAlexis NdjoloRoland Ndip Ndip

Published in: PloS one (2023)

Among APHI in settings like Cameroon, there is a wide genetic diversity of HIV-1, driven by CRF02_AG and with potential novel clades due to ongoing recombination events. Duration of treatment significantly reduces the risk of disease progression.

Keyphrases

antiretroviral therapy
hiv infected
genetic diversity
hiv positive
human immunodeficiency virus
hiv infected patients
hiv aids
quantum dots
hiv testing
dna repair
metabolic syndrome
type diabetes
highly efficient
skeletal muscle
climate change
replacement therapy
smoking cessation